| 1 |
33704530 | Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. | 2021 May |
1 |
| 2 |
29951065 | Monocyte-Derived Dendritic Cells Differentiated in the Presence of Lenalidomide Display a Semi-Mature Phenotype, Enhanced Phagocytic Capacity, and Th1 Polarization Capability. | 2018 |
1 |
| 3 |
30104242 | Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia. | 2018 Oct 1 |
3 |
| 4 |
27698446 | Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid. | 2017 Jan |
1 |
| 5 |
27889516 | Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma. | 2017 Feb |
1 |
| 6 |
27668268 | Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3+CD8+ T cells against Various Solid Tumors. | 2015 Jun |
2 |
| 7 |
23609417 | Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma. | 2013 Jun |
2 |
| 8 |
18980990 | Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy. | 2008 Nov 1 |
2 |